Medtronic Plc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Medtronic Plc in the first quarter 2026?
Medtronic Plc achieved a return on average equity (ROE) of 10.64 % in its first quarter 2026, which is below Medtronic Plc's average return on equity, which stands at 13.76%.

ROE has advanced compared to 9.91% in the fourth quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 37 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2026 from 1401 to 1686.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jul 31 2026) I. Quarter	(Apr 24 2026) IV. Quarter	(Jan 23 2026) III. Quarter	(Oct 24 2025) II. Quarter	(Jul 25 2025) I. Quarter
Y / Y Equity Change	5.64 %	3.76 %	-4.29 %	0.29 %	-
Y / Y Net Income Change	41.26 %	18.66 %	-11.74 %	8.06 %	-0.19 %
Net Income (TTM) in Millions	5,269	4,837	4,639	4,792	4,689
Return On Equity (TTM)	10.64 %	9.91 %	9.59 %	9.8 %	9.59 %
MDT's Total Ranking	# 1686	# 1401	# 1428	# 1402	# 1804
Equity (TTM) in Millions	50,850	50,072	48,256	48,857	48,133
Seq. Equity Change	1.55 %	3.76 %	-1.23 %	1.5 %	-0.25 %
Seq. Net Income Change	17.47 %	9.48 %	-16.73 %	31.9 %	-1.32 %

Back to MDT Management Effectiveness >> MDT's 5 Years Annual ROE >> Compare MDT ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 38
Sector	# 152
Overall	# 1686

Return On Equity Statistics
High	Average	Low
27 %	13.76 %	4.51 %
		(Oct 26 2018)

MDT Annual Return On Equity	(Apr 24 2026) 2026	(Apr 25 2025) 2025	(Apr 26 2024) 2024	(Apr 28 2023) 2023	(Apr 29 2022) 2022
Total Equity in Millions	50,072	48,256	50,420	51,665	52,722
Y / Y Equity Change	3.76 %	-4.29 %	-2.41 %	-2 %	2.17 %
Net Income in Millions	4,837	4,691	3,705	3,784	5,062
Y / Y Net Income Change	3.11 %	26.61 %	-2.09 %	-25.25 %	39.45 %
Return On Equity	9.66 %	9.72 %	7.35 %	7.32 %	9.6 %

Back to MDT Management Effectiveness >> MDT's 5 Years Annual ROE >> Compare MDT ROE to its Competitors

Annual Roe Comment

In 2026 ROE fell to 9.66 %, despite net income growth.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
MDT's' Return on Equity at Yahoo Finance
MDT's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for MDT's Competitors
Subscribers only: Roe for Medtronic Plc's Suppliers
Subscribers only: Return On Equity for MDT's Customers

Companies with similar Return On Equity at Jul 31 2026, within Healthcare Sector	ROE
Solventum Corporation	28.96 %
Pacs Group Inc	27.00 %
Sotera Health Company	26.75 %
Insulet Corporation	26.69 %
Bioventus Inc	25.96 %
Johnson and Johnson	25.74 %
Encompass Health Corporation	25.52 %
Resmed Inc	24.21 %
Healthcare Services Group Inc	24.12 %
Electromed Inc	23.65 %
Iradimed Corporation	23.45 %
Vertex Pharmaceuticals Inc	23.31 %
Lantheus Holdings Inc	23.27 %
Msa Safety Inc	23.15 %
Prestige Consumer Healthcare Inc	21.77 %
Jazz Pharmaceuticals Plc	21.37 %
Neurocrine Biosciences Inc	21.13 %
Universal Health Services Inc	20.89 %
Puma Biotechnology Inc	20.85 %
Entera Bio Ltd	20.82 %
United Therapeutics Corporation	20.18 %
Ligand Pharmaceuticals Incorporated	20.06 %
Harmony Biosciences Holdings inc	20.06 %
Pediatrix Medical Group Inc	19.89 %
Theravance Biopharma inc	19.40 %
Krystal Biotech Inc	19.34 %
Ani Pharmaceuticals Inc	19.33 %
Brightspring Health Services Inc	18.93 %
Sbc Medical Group Holdings Incorporated	18.69 %
West Pharmaceutical Services Inc	18.51 %

Date modified: 2026-09-26T07:25:11+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.